tirzepatide nih Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health Tirzepatide | Weight Loss Injections

Losing weight can be challenging, but advancements in medication offer new avenues for support

Learn safer, trial-backed alternatives.

Food and Drug Administration has accepted two Abbreviated New Drug Applications (ANDAs) from Sandoz for proposed generic tirzepatide autoinjectors

GLP-1 Receptor Agonists (GLP-1RAs) may have anti-cancer benefits beyond weight loss, compared to weight loss surgery, says a new study.

Cipla will market Eli Lilly's weight loss drug Yurpeak in India, manufactured by Lilly, offering personalized treatment options.

AOD 9604 peptide for fat loss, explained by Perfect B in Doral, FL: how the HGH fragment works, real results, safety, and how it compares to semaglutide.